Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
08/1995
08/09/1995EP0562016B1 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
08/09/1995CN1106388A 1,2-dihydro-2-oxo-pyridine
08/09/1995CN1106387A 1,2-dihydro-2-oxo-3-methyl-sulfonylaminomethyl-pyridine
08/08/1995US5440035 Leukotriene antagonists; antiallergens, antiinflammatory agents
08/08/1995US5439929 Bicyclic carbamates, pharmaceutical compositions and use
08/08/1995US5439925 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics
08/04/1995CA2141728A1 3-(2-aminoethyl)-4-¬3-(trifluoromethyl)benzoyl|-3, 4-dihydro-2h-1,4- benzoxazine derivatives, process for their preparation and their therapeutic application
08/03/1995WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents
08/03/1995WO1995020393A1 Use of mometasone furoate for treating airway passage and lung diseases
08/03/1995WO1995020386A1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
08/03/1995WO1995020378A1 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker
08/03/1995CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents
08/02/1995EP0664802A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders
08/02/1995EP0664707A1 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma.
08/02/1995EP0664705A1 Use of ergoline derivatives for the treatment of glaucoma
08/02/1995CN1106007A Novel sulfonylamino pyrimidines
08/01/1995US5438073 Dermatological and/or cosmetological composition containing retinoids
08/01/1995US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders
08/01/1995US5438060 Method of reducing elevated intraocular pressure
08/01/1995CA1336500C Opthalmic suspensions
08/01/1995CA1336490C Pharmacological treatment of ocular development
07/1995
07/27/1995WO1995019978A1 Tetracyclic derivatives, process of preparation and use
07/27/1995WO1995019968A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
07/27/1995WO1995019964A1 Ep2-receptor agonists as agents for lowering intraocular pressure
07/27/1995WO1995019961A1 Metalloproteinase inhibitors
07/27/1995WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
07/27/1995WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995WO1995019956A1 Metalloproteinase inhibitors
07/27/1995WO1995019952A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
07/27/1995WO1995019764A1 Cis-hydroxyproline analogs for eye treatment
07/27/1995CA2181788A1 Cis-hydroxyproline analogs for eye treatment
07/27/1995CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995CA2181581A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
07/20/1995WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/20/1995WO1995019362A1 Dihydro pyrazolopyrroles
07/20/1995WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists
07/20/1995WO1995019165A1 Method of treating disorders of the eye
07/20/1995WO1995019108A1 Method for delipidation of skin and cerumen removal
07/20/1995CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists
07/19/1995EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof
07/19/1995EP0662962A1 Substituted pyrimidines for control of diabetic complications
07/18/1995US5434180 Skin disorders; retinoid activity; rheumatoid psoriasis;
07/18/1995US5434173 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity
07/18/1995US5434167 Imidazolines N-substituted by a biphenylmethyl group, their medical use and the pharmaceutical compositions therefor
07/18/1995US5434162 Quinolinyl/isoquinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
07/18/1995US5434158 Asthma
07/13/1995WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
07/13/1995CA2180340A1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
07/13/1995CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
07/12/1995EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor
07/12/1995EP0661968A1 Pharmaceutical composition containing carbachol and other cholinergic substances
07/12/1995EP0630232A4 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor.
07/11/1995US5432199 Use of acetyl D-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
07/06/1995WO1995018132A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
07/06/1995WO1995018103A1 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof
07/06/1995WO1995018102A1 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
07/06/1995WO1995018101A1 Prostaglandin derivative, salt thereof, and use thereof
07/06/1995WO1995017904A2 Botulinum toxins for treating various disorders and associated pain
07/06/1995WO1995016435A3 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
07/06/1995CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition
07/06/1995CA2180014A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
07/06/1995CA2179981A1 Prostaglandin derivative, salt thereof, and use thereof
07/05/1995EP0661292A1 Orally active renin inhibitors
07/05/1995EP0661260A1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use
07/05/1995EP0661258A1 Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses
07/05/1995EP0661055A1 Pharmaceutical formulation containing clobetasone and tobramycin and applications thereof
07/05/1995EP0660836A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds
07/05/1995EP0660717A1 Aminosteroids for ophthalmic use
07/05/1995EP0660716A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
07/05/1995EP0660703A1 Topical carbonic anhydrase inhibitor composition
07/04/1995US5430060 Aldose reductase inhibitor
07/04/1995CA1336177C Method of producing high molecular weight sodium hyaluronate by fermentation of streptococcus
06/1995
06/29/1995WO1995017410A1 Heterocyclic compounds
06/29/1995WO1995017181A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
06/29/1995WO1995017178A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
06/29/1995CA2177851A1 Heterocyclic compounds
06/29/1995CA2155098A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
06/28/1995EP0659430A1 Use of benzo[g]quinolines in the treatment of glaucoma and for the prevention of progressive atrophy of the optic nerve
06/27/1995US5428033 Saturated hydroxyalkylquinoline acids as leukotriene antagonists
06/27/1995US5428030 Method of reducing elevated intraocular pressure
06/27/1995CA1336099C Urea based lipoxygenase compounds
06/22/1995WO1995016707A1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
06/22/1995WO1995016685A1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
06/22/1995WO1995016683A1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995WO1995016449A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995WO1995016435A2 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995CA2179147A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
06/22/1995CA2179006A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995CA2178218A1 Analogues of hgh-rh (1-29)nh2 having antagonistic activity
06/22/1995CA2138421A1 Use of benzo [g] quinolines
06/21/1995EP0658553A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof
06/21/1995CN1103782A Anti-allergic pharmaceutical composition for ophthalmic topical admini stration
06/20/1995US5426107 Pyrazolopyrimidinone antianginal agents
06/20/1995US5426103 Certain macrocyclic lactam derivatives
06/16/1995CA2138181A1 Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
06/16/1995CA2137897A1 Biaromatic compounds derived from amides; pharmaceutical and cosmetic compositions containing the same and their uses
06/16/1995CA2137896A1 Propynyl biaromatic compounds; pharmaceutical and cosmetic compositions containing the same and their uses
06/16/1995CA2137739A1 Polycyclic aromatic compounds; pharmaceutical and cosmetic compositions containing the same and their use
06/15/1995WO1995015979A1 Pretargeting methods and compounds
1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 531